- Home
- ARDX vs ATTO Comparison
ARDX vs ATTO Comparison
Compare ARDX & ATTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARDX | ATTO |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 975.9M | 919.3M |
| IPO Year | 2014 | 2026 |
Fundamental Metrics
Financial Performance| Metric | ARDX | ATTO |
|---|---|---|
| Price | $3.42 | $22.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $15.14 | N/A |
| AVG Volume (30 Days) | ★ 3.9M | 197.5K |
| Earning Date | 04-30-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,607,000.00 | N/A |
| Revenue This Year | $37.75 | N/A |
| Revenue Next Year | $34.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.34 | $16.15 |
| 52 Week High | $8.40 | $28.00 |
Technical Indicators
Market Signals| Indicator | ARDX | ATTO |
|---|---|---|
| Relative Strength Index (RSI) | 24.11 | 58.30 |
| Support Level | N/A | $17.50 |
| Resistance Level | $3.92 | $24.89 |
| Average True Range (ATR) | 0.12 | 2.69 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 14.53 | 57.01 |
Price Performance
Historical ComparisonAbout ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.